A Randomized, Comparative Effectiveness Study of Complete Revascularization with Percutaneous Coronary Intervention to Treat Coronary Artery Disease vs Medical Management Alone in Patients with Symptomatic Aortic Valve Stenosis undergoing Elective Transfemoral Transcatheter Aortic Valve Replacement: The COMPLETE TAVR Study,
Role: Investigator,
University of British Columbia,
(04/2024 - 04/2025)
Status: Approved
For Profit Organization
SELUTION SLR™ 014 ISR: A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 Drug Eluting Balloon in the Treatment of Subjects with In-stent Restenosis,
Role: PI,
MedAlliance,
(06/2024 - 06/2025)
Status: Approved
SSO2 THERAPY: AMIHOT III STUDY: A MULTI-CENTER RANDOMIZED POST-APPROVAL EVALUATION OF THE DELIVERY OF INTRACORONARY HYPEROXEMIC SUPERSATURATED OXYGEN THERAPY FOR 60 MINUTES IN ANTERIOR ACUTE MYOCARDIAL INFARCTION PATIENTS WITH SUCCESSFUL REPERFUSION (VIA PCI) = SIX HOURS AFTER SYMPTOM ONSET COMPARED TO STANDARD THERAPY,
Role: PI,
TherOx, Inc.,
(05/2024 - 05/2025)
Status: Approved
Ultrasound-based renal sympathetic denervation as adjunctive upstream therapy during atrial fibrillation ablation: a pilot study (ULTRA-HFIB),
Role: Investigator,
ReCor Medical, Inc.,
(01/2025 - 01/2026)
Status: Approved
Impella®-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial,
Role: Investigator,
ABIOMED, Inc.,
(01/2025 - 01/2026)
Status: Approved